$IPA a Biotherapeutic research group involved in combining its leading antibody discovery services with highly advanced artificial intelligence. The company seeks to help its pharmaceutical partners in discovering antibodies more effectively. The company has come up with its artificial intelligence-powered platform named LENS.
https://www.benzinga.com/pressreleases/23/05/...li-skyx-az
https://www.benzinga.com/pressreleases/23/05/...li-skyx-az